USFDA gives nod to Alembic Pharma for Vortioxetine tablets

Vortioxetine tablets are indicated for the treatment of Major Depressive Disorder

87
USFDA
Picture: Pixabay

Last Updated on January 9, 2022 by The Health Master

Alembic Pharmaceuticals today received tentative approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Vortioxetine tablets of 5 mg, 10 mg, 15 mg, and 20 mg.

The tentatively approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product Trintellix tablets, 5 mg, 10 mg, 15 mg, and 20 mg of Takeda Pharmaceuticals, the company said via a statement.

Vortioxetine tablets are indicated for the treatment of Major Depressive Disorder (MDD), and have an estimated market size of $1249 million for the twelve months ending September 2021, according to IQVIA, it added.

The statement further stated that Alembic is currently in litigation with H. Lundbeck in the Court of Appeals for the Federal Circuit and that the launch of the product will depend on the litigation outcome.

USFDA gives nod to Alembic for generic drug to treat Parkinson’s disease

USFDA gives nod to Alembic Pharma for Doxycycline Hyclate tablets

USFDA gives tentative nod to Zydus Cadila for Pimavanserin capsules

USFDA gives tentative nod to Amphastar Pharma for Vasopressin injection

USFDA gives nod to Granules India for Prazosin HCL capsules

USFDA gives nod to Lupin for this drug to treat Kidney disease

Covid: Govt warns against self-medication, steroid use

Molnupiravir has serious safety concerns: ICMR

USFDA gives nod to Alembic for generic drug to treat Parkinson’s…

No Paracetamol, Painkillers recommended after Covaxin jab

Govt is expected to amend New Drugs and Clinical Trial Rules 2019

Chemists told to stock up on key medicines

Govt to allow parallel submission of these applications for New Drugs

DCGI directs all State Drugs Controllers to implement ONDLS portal

DTAB recommends Bar code on top 300 brands of drug products

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news

Enter your email address:

Delivered by FeedBurner